Cargando…

C-peptide and Retinal Microangiopathy in Diabetes

Increased extracellular matrix (ECM) protein deposition and capillary basement membrane (BM) thickening are characteristic features of diabetic retinal microangiopathy. Recent observations in the authors' laboratories suggest that high glucose in endothelial cells as well as diabetes causes up-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Subrata, Khan, Zia Ali, Cukiernik, Mark, Zhang, Weixian, Sima, Anders A. F.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478616/ https://www.ncbi.nlm.nih.gov/pubmed/15198374 http://dx.doi.org/10.1080/15438600490424569

Ejemplares similares

Alteration of Endothelins: A Common Pathogenetic Mechanism in Chronic Diabetic Complications
por: Chakrabarti, Subrata, et al.
Publicado: (2002)

Type 1 Diabetic Neuropathy and C-peptide
por: Sima, Anders A. F., et al.
Publicado: (2004)

C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
por: Li, Zhen-guo, et al.
Publicado: (2002)

C-Peptide as a Remedy for Diabetic Microangiopathy?
por: Waldhäusl, Werner
Publicado: (2013)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat
por: Sima, Anders A. F., et al.
Publicado: (2008)

Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy
por: Khan, Zia A., et al.
Publicado: (2007)

Differential effects of curcumin on vasoactive factors in the diabetic rat heart
por: Farhangkhoee, Hana, et al.
Publicado: (2006)

C-peptide and Central Nervous System Complications in Diabetes
por: Li, Zhen-guo, et al.
Publicado: (2004)

The Insulin-Like Growth Factor System and Neurological Complications in Diabetes
por: Sima, Anders A. F., et al.
Publicado: (2003)

Dynamic Changes of Neuroskeletal Proteins in DRGs Underlie Impaired Axonal Maturation and Progressive Axonal Degeneration in Type 1 Diabetes
por: Kamiya, Hideki, et al.
Publicado: (2009)

The C-peptide Signaling
por: Grunberger, George, et al.
Publicado: (2004)

Has C-Peptide Come of Age?
por: Sima, Anders A. F.
Publicado: (2001)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Inhibition of HDAC6 Attenuates Diabetes-Induced Retinal Redox Imbalance and Microangiopathy
por: Abouhish, Hossameldin, et al.
Publicado: (2020)

The Unconventional Role of Acid Sphingomyelinase in Regulation of Retinal Microangiopathy in Diabetic Human and Animal Models
por: Opreanu, Madalina, et al.
Publicado: (2011)

Assessment of Retinal Microangiopathy in Chronic Kidney Disease Patients
por: Kasumovic, Aida, et al.
Publicado: (2020)

Correlation Between Coronary and Retinal Microangiopathy in Patients With STEMI
por: Sideri, Anna-Maria, et al.
Publicado: (2023)

Assesment of Conjunctival Microangiopathy in a Patient with Diabetes Mellitus Using the Retinal Function Imager
por: Stuebiger, Nicole, et al.
Publicado: (2015)

Regenerative Therapies for Diabetic Microangiopathy
por: Bassi, Roberto, et al.
Publicado: (2012)

Diabetic endothelial microangiopathy and pulmonary dysfunction
por: Zhang, Lanlan, et al.
Publicado: (2023)

Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relevance in Diabetic Retinopathy
por: Ruiz, Michael Anthony, et al.
Publicado: (2015)

SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1
por: Mortuza, Rokhsana, et al.
Publicado: (2015)

Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes
por: Biswas, Saumik, et al.
Publicado: (2019)

The Role of PKM2 in Diabetic Microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

RNA‐binding proteins in diabetic microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture
por: Filek, Richard, et al.
Publicado: (2019)

Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot Ulcer
por: Tomita, Masuomi, et al.
Publicado: (2016)

Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy
por: ZHANG, XIAOYAN, et al.
Publicado: (2014)

Study on the Interaction between the Characteristics of Retinal Microangiopathy and Risk Factors for Cerebral Small Vessel Disease
por: Tang, Qian, et al.
Publicado: (2022)

Proinsulin C-peptide - A Consensus Statement
por: Sima, Anders A. F., et al.
Publicado: (2001)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Diabetic Retinopathy: From Pathogenesis to Treatment
por: Chakrabarti, Subrata
Publicado: (2007)

Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study
por: de Mello, Vanessa Derenji, et al.
Publicado: (2021)

Serum vitamin K(1) associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes
por: Bøgh Andersen, Ida, et al.
Publicado: (2020)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Haptoglobin Polymorphism in Individuals with Type 2 Diabetic Microangiopathy
por: Amiri, Ahmad Ahmadzadeh, et al.
Publicado: (2013)

Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa
por: Somboonwong, Juraiporn, et al.
Publicado: (2016)

Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
por: Goldney, Jonathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_toah6325p3vcj7gecd6v29hhtm